Direct tissue plasminogen activator administration through a microinjection device in a pig model of retinal vein thrombosis

Author： Zhang Xiaoli   Ma Zhizhong   Hu Yuntao   Fan Jianguo  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.24, Iss.4, 2002-04, pp. : 263-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Intravitreal Injection of Tissue Plasminogen Activator on Full-Field Electroretinogram in Patients with Macular Oedema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 226, Iss. 2, 2011-05 ,pp. : 81-86

Karger

Access to resources Recommend Favorite

Visual Outcome after Treatment with Low-Dose Recombinant Tissue Plasminogen Activator or Hemodilution in Ischemic Central Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 213, Iss. 6, 1999-11 ,pp. : 360-366

Karger

Access to resources Recommend Favorite

Fibrinolytic Therapy with Low-Dose Recombinant Tissue Plasminogen Activator in Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 212, Iss. 6, 1998-09 ,pp. : 394-398

Karger

Access to resources Recommend Favorite

Retinal Toxicity of Commercial Tissue Plasminogen Activator Is Mediated by the Induction of Nitric Oxide in the Mouse Retinal Primary Cells

By Oh Hyun-Sub   Kwon Oh   Chung In   Lee Sung   Koh Hyoung   Lee Sung-Ho   Lee Joon  

Current Eye Research, Vol. 30, Iss. 4, 2005-04 ,pp. : 291-297

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Suprachoroidal Hemorrhage with Tissue Plasminogen Activator

By  

Ophthalmologica, Vol. 212, Iss. 2, 1998-01 ,pp. : 120-125

Karger

Access to resources Recommend Favorite